Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 96

1.

A rat monoclonal antibody that recognizes pro- and active MMP-7 indicates polarized expression in vivo.

Fingleton B, Powell WC, Crawford HC, Couchman JR, Matrisian LM.

Hybridoma (Larchmt). 2007 Feb;26(1):22-7.

PMID:
17316082
[PubMed - indexed for MEDLINE]
Free PMC Article
2.

Binding of alpha5 monoclonal antibody to cell surface alpha5beta1 integrin modulates MMP-2 and MMP-7 activity in B16F10 melanoma cells.

Mitra A, Chakrabarti J, Chatterjee A.

J Environ Pathol Toxicol Oncol. 2003;22(3):167-78.

PMID:
14529092
[PubMed - indexed for MEDLINE]
3.

Heparan sulfate proteoglycans as extracellular docking molecules for matrilysin (matrix metalloproteinase 7).

Yu WH, Woessner JF Jr.

J Biol Chem. 2000 Feb 11;275(6):4183-91.

PMID:
10660581
[PubMed - indexed for MEDLINE]
Free Article
4.

[Preparation, identification and application of monoclonal antibody against matrix metalloproteinases-2].

You M, Liu W, Xu ZS, Song LH.

Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2012 Nov;28(11):1177-81. Chinese.

PMID:
23127409
[PubMed - indexed for MEDLINE]
5.

Expression and tissue localization of membrane-types 1, 2, and 3 matrix metalloproteinases in human invasive breast carcinomas.

Ueno H, Nakamura H, Inoue M, Imai K, Noguchi M, Sato H, Seiki M, Okada Y.

Cancer Res. 1997 May 15;57(10):2055-60.

PMID:
9158005
[PubMed - indexed for MEDLINE]
Free Article
6.

Matrilysin (MMP-7) promotes invasion of ovarian cancer cells by activation of progelatinase.

Wang FQ, So J, Reierstad S, Fishman DA.

Int J Cancer. 2005 Mar 10;114(1):19-31.

PMID:
15523695
[PubMed - indexed for MEDLINE]
7.

The effects of 1 alpha,25-dihydroxyvitamin D(3) on matrix metalloproteinase and prostaglandin E(2) production by cells of the rheumatoid lesion.

Tetlow LC, Woolley DE.

Arthritis Res. 1999;1(1):63-70. Epub 1999 Oct 14.

PMID:
11056661
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Expression and tissue localization of membrane-type 1, 2, and 3 matrix metalloproteinases in human astrocytic tumors.

Nakada M, Nakamura H, Ikeda E, Fujimoto N, Yamashita J, Sato H, Seiki M, Okada Y.

Am J Pathol. 1999 Feb;154(2):417-28.

PMID:
10027400
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Matrix metalloproteinase expression increases after cerebral focal ischemia in rats: inhibition of matrix metalloproteinase-9 reduces infarct size.

Romanic AM, White RF, Arleth AJ, Ohlstein EH, Barone FC.

Stroke. 1998 May;29(5):1020-30.

PMID:
9596253
[PubMed - indexed for MEDLINE]
Free Article
10.

Expression of matrix metalloprotease-2, -7 and -9 on human colon, liver and bile duct cell lines by enteric and gastric Helicobacter species.

Yanagisawa N, Geironson L, Al-Soud WA, Ljungh S.

FEMS Immunol Med Microbiol. 2005 May 1;44(2):197-204.

PMID:
15866216
[PubMed - indexed for MEDLINE]
11.

Matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression and synthetic matrix metalloproteinase-2 inhibitor binding in ovarian carcinomas and tumor cell lines.

Afzal S, Lalani el-N, Foulkes WD, Boyce B, Tickle S, Cardillo MR, Baker T, Pignatelli M, Stamp GW.

Lab Invest. 1996 Feb;74(2):406-21.

PMID:
8780160
[PubMed - indexed for MEDLINE]
12.

Membrane type (MT) 1-matrix metalloproteinase (MMP) and MMP-2 expression in ligature-induced periodontitis in the rat.

Achong R, Nishimura I, Ramachandran H, Howell TH, Fiorellini JP, Karimbux NY.

J Periodontol. 2003 Apr;74(4):494-500.

PMID:
12747454
[PubMed - indexed for MEDLINE]
13.

In vitro inhibition of human MMP-2 collagenolytic and gelatinolytic activity by neutralizing monoclonal antibodies.

Emara M, Wozniak M.

Immunol Invest. 2010;39(8):833-48. doi: 10.3109/08820139.2010.502948. Epub 2010 Aug 18.

PMID:
20718661
[PubMed - indexed for MEDLINE]
14.

Quantitative immunohistochemical and in situ hybridization analysis of metalloproteinases in prostate cancer.

Cardillo MR, Di Silverio F, Gentile V.

Anticancer Res. 2006 Mar-Apr;26(2A):973-82.

PMID:
16619495
[PubMed - indexed for MEDLINE]
Free Article
15.
16.

Immunological characterization of cell-surface and soluble forms of membrane type 1 matrix metalloproteinase in human breast cancer cells and in fibroblasts.

Li H, Bauzon DE, Xu X, Tschesche H, Cao J, Sang QA.

Mol Carcinog. 1998 Jun;22(2):84-94.

PMID:
9655252
[PubMed - indexed for MEDLINE]
17.

Type-specific dysregulation of matrix metalloproteinases and their tissue inhibitors in end-stage heart failure patients: relationship between MMP-10 and LV remodelling.

Wei Y, Cui C, Lainscak M, Zhang X, Li J, Huang J, Zhang H, Zheng Z, Hu S.

J Cell Mol Med. 2011 Apr;15(4):773-82. doi: 10.1111/j.1582-4934.2010.01049.x.

PMID:
20219015
[PubMed - indexed for MEDLINE]
18.

The tumor-associated antigen 90K/Mac-2-binding protein secreted by human colon carcinoma cells enhances extracellular levels of promatrilysin and is a novel substrate of matrix metalloproteinases-2, -7 (matrilysin) and -9: Implications of proteolytic cleavage.

Ulmer TA, Keeler V, André S, Gabius HJ, Loh L, Laferté S.

Biochim Biophys Acta. 2010 Mar;1800(3):336-43. doi: 10.1016/j.bbagen.2009.07.030. Epub 2009 Aug 7.

PMID:
19665518
[PubMed - indexed for MEDLINE]
Free Article
19.

Time course of matrix metalloproteases and tissue inhibitors in bleomycin-induced pulmonary fibrosis.

Oggionni T, Morbini P, Inghilleri S, Palladini G, Tozzi R, Vitulo P, Fenoglio C, Perlini S, Pozzi E.

Eur J Histochem. 2006 Oct-Dec;50(4):317-25.

PMID:
17213041
[PubMed - indexed for MEDLINE]
20.

Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.

Yamamoto M, Mohanam S, Sawaya R, Fuller GN, Seiki M, Sato H, Gokaslan ZL, Liotta LA, Nicolson GL, Rao JS.

Cancer Res. 1996 Jan 15;56(2):384-92.

PMID:
8542596
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk